Company to host investor webcast and conference call on February 12 at 7 a.m. PT / 10 a.m. ET Investor webcast will feature the clinical validation data and review commercial launch timeline BRISBANE, ...

A total of 641 eligible cases were enrolled from June 2022 to October 2023 from seven hospitals in China. The sensitivity rates for all syndromes ranged from 70.37% to 92.00%, with the highest rate ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, announced key milestones achieved in 2025, a year defined by progress, innovation, and growth. Vektor’s flagship ...

There have been some interesting failures recently in Alzheimer’s trials. Two are notable because they’re aimed outside the usual amyloid zone. Novo Nordisk (NVO) recently reported that semaglutide ...

n = 345 adults seeking web based ADHD assessment (predominantly female; mean age = 35). Sensitivity = 80.6% and Positive Predictive Value = 94.9%. False positive rate = 12% versus 56% for the clinical ...

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. It affects >30 million people worldwide each year, has a mortality rate of up to 10%, and is a ...

Artificial intelligence-enabled medical devices with no clinical validation were more likely to be the subject of recalls, according to a study published in JAMA Health Forum. The study, published on ...

A pair of CROs from opposite sides of the Atlantic Ocean are merging to form a global organization. Evestia Clinical and Atlantic Research Group are joining forces to bring clients expertise in ...

Merriam, Kansas-based Advent Health Shawnee Mission Hospital has filed a lawsuit against Blue Cross and Blue Shield of Kansas City for artificial intelligence-driven technology that the provider said ...

Beta-CORRECT study to be presented at ASCO 2025 confirms the clinical utility of the molecular residual disease (MRD) test, Oncodetect™, for recurrence monitoring in stage II–IV colorectal cancer ...

South San Francisco, CA (April 8, 2025) - Today, Mirvie announced results of a breakthrough study published in Nature Communications, revealing new advances in the biological understanding of ...